INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT — Neutral
ADCT PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA ("ADC Therapeutics" or the "Company") (NYSE: ADCT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of New Era Energy & Digital, Inc. - NUAI — Neutral
NUAI PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of New Era Energy & Digital, Inc. ("New Era" or the "Company") (NASDAQ: NUAI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Fermi Inc. of Class Action Lawsuit and Upcoming Deadlines - FRMI — Neutral
FRMI PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fermi Inc. ("Fermi" or the "Company") (NASDAQ: FRMI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Klarna Group PLC of Class Action Lawsuit and Upcoming Deadlines - KLAR — Neutral
KLAR PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Klarna Group PLC ("Klarna" or the "Company") (NYSE: KLAR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Varonis Systems, Inc. of Class Action Lawsuit and Upcoming Deadlines - VRNS — Neutral
VRNS PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Varonis Systems, Inc. ("Varonis" or the "Company") (NASDAQ: VRNS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM — Neutral
QNTM PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed on behalf of shareholders of Quantum Biopharma Ltd. ("Quantum" or the "Company") (NASDAQ: QNTM).
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in agilon health, inc. of Class Action Lawsuit and Upcoming Deadlines - AGL — Neutral
AGL PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against agilon health, inc. ("Agilon" or the "Company") (NYSE: AGL).
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST — Neutral
RXST PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Pomerantz Law Firm Announces the Filing of a Class Action Against SLM Corporation and Certain Officers - SLM — Neutral
SLM PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against SLM Corporation ("SLM" or the "Company") (NASDAQ: SLM) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-18834, is on behalf of a class consisting of all persons and entities other than Defendants that invested in SLM securities between July 25, 2025 and August 14, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Instil Bio, Inc. - TIL — Neutral
TIL PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Instil Bio, Inc. ("Instil" or the "Company") (NASDAQ: TIL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO — Neutral
ZBIO PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zenas BioPharma, Inc. ("Zenas" or the "Company") (NASDAQ: ZBIO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Pomerantz Law Firm Announces the Filing of a Class Action Against CoreWeave, Inc. and Certain Officers - CRWV — Neutral
CRWV PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against CoreWeave, Inc. ("CoreWeave" or the "Company") (NASDAQ: CRWV) and certain officers. The class action, filed in the United States District Court for the Western District of Texas, and docketed under 26-cv-00355, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired CoreWeave securities between March 28, 2025 and December 15, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT — Neutral
CORT PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO — Neutral
ORGO PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE — Neutral
RARE PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NASDAQ: RARE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutanix, Inc. - NTNX — Neutral
NTNX PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nutanix, Inc. ("Nutanix" or the "Company") (NASDAQ: NTNX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO — Neutral
MREO PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc ("Mereo" or the "Company") (NASDAQ: MREO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BigBear.ai Holdings, Inc. - BBAI — Neutral
BBAI PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of BigBear.ai Holdings, Inc. ("BigBear" or the "Company") (NYSE: BBAI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Coupang, Inc. of Class Action Lawsuit and Upcoming Deadlines - CPNG — Neutral
CPNG PRNewsWire — January 22, 2026NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Coupang, Inc. ("Coupang" or the "Company") (NYSE: CPNG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
Community Healthcare Trust: Attractive Valuation Ahead Of Q4 2025 Earnings — Positive
CHCT Seeking Alpha — January 22, 2026Community Healthcare Trust shares are off to a strong start in 2026, building on momentum achieved in late 2025. Even so, CHCT stock remains down year-over-year despite several catalysts ahead of its Q4 2025 earnings. Indeed I expect CHCT to report marginally higher AFFO, driven by lower funding costs, portfolio rotation, and higher occupancy.
